Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial

NCT05686733 is registered in ClinicalTrials.gov with Galaxy Therapeutics INC as lead sponsor.

NCT NCT05686733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05686733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-SEAL™IT: Saccular Endovascular Aneurysm Lattice System First In Human Interventional Trial
Lead sponsor
Galaxy Therapeutics INC
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2022
Completion date
February 17, 2024
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysm, aneurysm, ruptured, aneurysms saccular